CN Patent

CN105287407B — 一种注射用磷酸特地唑胺

Assigned to SHANGHAI BOYUE BIOTECHNOLOGY CO Ltd · Expires 2018-09-21 · 8y expired

What this patent protects

本发明属药物制剂领域，涉及一种注射用磷酸特地唑胺。该注射用冻干制剂以磷酸特地唑胺为有效成分，添加冻干保护剂、pH调节剂，经过药液配制、灌装、冷冻干燥，得到注射用磷酸特地唑胺粉针剂。本发明提供的冷冻干燥工艺是根据磷酸特地唑胺性质特点而设计，工艺简单方便操作、生产周期短、适应工业化规模生产，同时能够提供低水分的产品，克服了注射用磷酸特地唑胺在储存过程中发生水解等问题，提高产品的质量及稳定性。

USPTO Abstract

本发明属药物制剂领域，涉及一种注射用磷酸特地唑胺。该注射用冻干制剂以磷酸特地唑胺为有效成分，添加冻干保护剂、pH调节剂，经过药液配制、灌装、冷冻干燥，得到注射用磷酸特地唑胺粉针剂。本发明提供的冷冻干燥工艺是根据磷酸特地唑胺性质特点而设计，工艺简单方便操作、生产周期短、适应工业化规模生产，同时能够提供低水分的产品，克服了注射用磷酸特地唑胺在储存过程中发生水解等问题，提高产品的质量及稳定性。

Drugs covered by this patent

Patent Metadata

Patent number
CN105287407B
Jurisdiction
CN
Classification
—
Expires
2018-09-21
Drug substance claim
No
Drug product claim
No
Assignee
SHANGHAI BOYUE BIOTECHNOLOGY CO Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.